Influence of combined use of an atorvastatin and sulodexide on exchange of lipids and intravascular coagulation of a lymph
Abstract
It has recently been discovered that the disorder of lipid metabolism plays an important role in the pathogenesis of diabetic microangiopathies. Thus, breakdown of lipid metabolism during sugary diabetes leads to a breakdown of microcirculation by creating favorable conditions for activating lipid peroxidation and intravenous blood clotting. At the same time, the next stage of microcirculation, ie the study of the effects of lymphamerculosis and treatment on this system, remained unnoticed.
References
Ogura H, Gando S, Saitoh D et al. Japanese Association for Acute Medicine Sepsis Registry (JAAMSR) Study Group. Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. J Infect Chemother 2014;20:157–62.
Alzahrani SH, Ajjan RA. Coagulation and fibrinolysis in diabetes. Diab Vasc Dis Res 2010;7:260–73.
Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med 2007;262:157–72.
Giovannucci E, Harlan DM, Archer MC et al. Diabetes and cancer: a consensus report. Diabetes Care 2010;33:1674–85.
Hanatani T, Sai K, Tohkin M et al. Impact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients. Int J Clin Pharm 2015;37:537–45.
Hori K, Kobayashi N, Atsumi H et al. Changes in compliance with Japanese antiemetic guideline for chemotherapy-induced nausea and vomiting: a nationwide survey using a distributed research network. Support Care Cancer 2014;22:969–77.
Ueyama H, Hinotsu S, Tanaka S et al. Application of a self-controlled case series study to a database study in children. Drug Saf 2014;37:259–68.
Keywords
sulodexidine
lymph circulation аторвастатин
сулодексид
циркуляция лимфы atorvastatin
sulodeksidin
limfa dövranı